ARC Medical Inc. — SEC Form D Filing

ARC Medical Inc. filed an SEC Form D on August 10, 2026, reporting $118K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 10, 2026
Amount reported
$118K
Round stage
Seed
Industry
Medical Devices
Website
https://arcmedinc.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: BRITISH COLUMBIA, CANADA

Problem

Surgical adhesions are unwanted internal bands that can form after most surgical procedures, leading to pain, organ dysfunction, infertility, and potentially death.

Solution

ARC Medical develops JOCOAT™ and IPCOAT™, which are liquid medical devices designed to provide a temporary physical barrier throughout the entire surgical site to prevent or reduce the formation of surgical adhesions.

Verdict

Investors backed ARC Medical's seed round based on the clear, unmet medical need for adhesion prevention, not on projected market share for a novel solution. They were implicitly betting on the technical efficacy of the liquid barrier and the company's ability to navigate regulatory hurdles for Class II or III devices. The small raise and unarticulated go-to-market strategy limited upside, indicating investors viewed this as a high-risk, early-stage technical validation play rather than an impending commercial breakthrough.

Source: SEC EDGAR Form D filing